En Route to New Therapeutic Options for Iron Overload Diseases: Matriptase-2 as a Target for Kunitz-Type Inhibitors.
about
Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic ReviewTargeting iron metabolism in drug discovery and deliveryTranscriptome analysis reveals TMPRSS6 isoforms with distinct functionalities.A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2.Functional diversity of TMPRSS6 isoforms and variants expressed in hepatocellular carcinoma cell lines
P2860
En Route to New Therapeutic Options for Iron Overload Diseases: Matriptase-2 as a Target for Kunitz-Type Inhibitors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
En Route to New Therapeutic Op ...... et for Kunitz-Type Inhibitors.
@en
type
label
En Route to New Therapeutic Op ...... et for Kunitz-Type Inhibitors.
@en
prefLabel
En Route to New Therapeutic Op ...... et for Kunitz-Type Inhibitors.
@en
P2093
P2860
P356
P1433
P1476
En Route to New Therapeutic Op ...... et for Kunitz-Type Inhibitors.
@en
P2093
Anna-Madeleine Beckmann
Annika Wilms
Eva Maurer
Marit Stirnberg
Michael Gütschow
Norbert Furtmann
Verena Lülsdorff
P2860
P304
P356
10.1002/CBIC.201500651
P577
2016-01-13T00:00:00Z